pH-Responsive Fluorescence Enhanced Nanogel for Targeted Delivery of AUR and CDDP Against Breast Cancer

References

• Lee JC, Shin EA, Kim B, et al. Auraptene induces apoptosis via myeloid cell Leukemia 1-mediated activation of caspases in PC3 and DU145 prostate cancer cells. Phytother Res. 2017;31:891–898. doi:10.1002/ptr.581028383142
   PubMed Web of Science ®Google Scholar
• Bibak B, Shakeri F, Barreto GE, Keshavarzi Z, Sathyapalan T, Sahebkar A. A review of the pharmacological and therapeutic effects of auraptene. BioFactors. 2019;45:867–879. doi:10.1002/biof.155031424600
   PubMed Web of Science ®Google Scholar
• Jalilzadeh N, Samadi N, Salehi R, et al. Novel nano-vehicle for delivery and efficiency of anticancer auraptene against colon cancer cells. Sci Rep. 2020;10:1606. doi:10.1038/s41598-020-58527-032005894
   PubMed Web of Science ®Google Scholar
• de Medina P, Genovese S, Paillasse MR, et al. Auraptene is an inhibitor of cholesterol esterification and a modulator of estrogen receptors. Mol Pharmacol. 2010;78:827–836. doi:10.1124/mol.110.06525020702762
   PubMed Web of Science ®Google Scholar
• Krishnan P, Kleiner-Hancock H. Effects of auraptene on IGF-1 stimulated cell cycle progression in the human breast cancer cell line, MCF-7. Int J Breast Cancer. 2012;2012:502092. doi:10.1155/2012/50209223320178
   PubMedGoogle Scholar
• Hasan M, Genovese S, Fiorito S, Epifano F, Witt-Enderby PA. Oxyprenylated phenylpropanoids bind to MT1 melatonin receptors and inhibit breast cancer cell proliferation and migration. J Nat Prod. 2017;80:3324–3329. doi:10.1021/acs.jnatprod.7b0085329144746
   PubMed Web of Science ®Google Scholar
• Jablonska K, Pula B, Zemla A, et al. Expression of melatonin receptor MT1 in cells of human invasive ductal breast carcinoma. J Pineal Res. 2013;54:334–345. doi:10.1111/jpi.1203223330677
   PubMed Web of Science ®Google Scholar
• Lai L, Yuan L, Cheng Q, Dong C, Mao L, Hill SM. Alteration of the MT1 melatonin receptor gene and its expression in primary human breast tumors and breast cancer cell lines. Breast Cancer Res Treat. 2009;118:293–305. doi:10.1007/s10549-008-0220-118979234
   PubMed Web of Science ®Google Scholar
• Saboor-Maleki S, Rassouli FB, Matin MM, Iranshahi M. Auraptene attenuates malignant properties of esophageal stem-like cancer cells. Technol Cancer Res Treat. 2017;16:519–527. doi:10.1177/153303461665011927207438
   PubMed Web of Science ®Google Scholar
• Moussavi M, Haddad F, Rassouli FB, Iranshahi M, Soleymanifard S. Synergy between auraptene, ionizing radiation, and anticancer drugs in colon adenocarcinoma cells. Phytother Res. 2017;31:1369–1375. doi:10.1002/ptr.586328675489
   PubMed Web of Science ®Google Scholar
• Tanaka T, de Azevedo M, Durán N, et al. Colorectal cancer chemoprevention by 2 beta-cyclodextrin inclusion compounds of auraptene and 4ʹ-geranyloxyferulic acid. Int J Cancer. 2010;126:830–840. doi:10.1002/ijc.2483319688830
   PubMed Web of Science ®Google Scholar
• Chen Y, Chen Q, Zhu Q, et al. Small molecular theranostic assemblies functionalized by doxorubicin-hyaluronic acid-methotrexate prodrug for multiple tumor targeting and imaging-guided combined chemo-photothermal therapy. Mol Pharm. 2019;16:2470–2480. doi:10.1021/acs.molpharmaceut.9b0007230995065
   PubMedGoogle Scholar
• Zhang Y, Yang D, Chen H, et al. Reduction-sensitive fluorescence enhanced polymeric prodrug nanoparticles for combinational photothermal-chemotherapy. Biomaterials. 2018;163:14–24. doi:10.1016/j.biomaterials.2018.02.02329452945
   PubMed Web of Science ®Google Scholar
• Chaurasia S, Patel R, Vure P, Mishra B. Oral naringenin nanocarriers: fabrication, optimization, pharmacokinetic and chemotherapeutic efficacy assessments. Nanomedicine (London, England). 2017;12:1243–1260. doi:10.2217/nnm-2016-0436
   PubMed Web of Science ®Google Scholar
• El-Shishtawy RM, Oliveira AS, Almeida P, Ferreira DP, Conceicao DS, Ferreira LF. Photophysical studies of a new water soluble indocarbocyanine dye adsorbed onto microcrystalline cellulose and beta-cyclodextrin. Molecules. 2013;18:5648–5668. doi:10.3390/molecules1805564823676472
   PubMed Web of Science ®Google Scholar
• Bai L, Yan H, Bai T, et al. High Fluorescent Hyperbranched Polysiloxane Containing β-Cyclodextrin for Cell Imaging and Drug Delivery. Biomacromolecules. 2019;20:4230–4240. doi:10.1021/acs.biomac.9b0121731633916
   PubMed Web of Science ®Google Scholar
• McFadden P, Frederick K, Argüello L, et al. UV fluorescent epoxy adhesives from noncovalent and covalent incorporation of coumarin dyes. ACS Appl Mater Interfaces. 2017;9:10061–10068. doi:10.1021/acsami.6b1321828233981
   PubMed Web of Science ®Google Scholar
• Xie X, Tang F, Shangguan X, et al. Two-photon imaging of formaldehyde in live cells and animals utilizing a lysosome-targetable and acidic pH-activatable fluorescent probe. Chem Commun. 2017;53:6520–6523.
   PubMed Web of Science ®Google Scholar
• Iliopoulos K, Krupka O, Gindre D, Sallé M. Reversible two-photon optical data storage in coumarin-based copolymers. J Am Chem Soc. 2010;132:14343–14345. doi:10.1021/ja104728520879764
   PubMed Web of Science ®Google Scholar
• Roozbehi S, Dadashzadeh S, Mirshahi M, Sadeghizadeh M, Sajedi RH. Targeted anticancer prodrug therapy using dextran mediated enzyme-antibody conjugate and beta-cyclodextrin-curcumin inclusion complex. Int J Biol Macromol. 2020;160:1029–1041. doi:10.1016/j.ijbiomac.2020.05.22532479931
   PubMed Web of Science ®Google Scholar
• DeDora DJ, Suhrland C, Goenka S, et al. Sulfobutyl ether beta-cyclodextrin (Captisol((R))) and methyl beta-cyclodextrin enhance and stabilize fluorescence of aqueous indocyanine green. J Biomed Mater Res B Appl Biomater. 2016;104:1457–1464. doi:10.1002/jbm.b.3349626251293
   PubMed Web of Science ®Google Scholar
• Alam MM, Han HS, Sung S, et al. Endogenous inspired biomineral-installed hyaluronan nanoparticles as pH-responsive carrier of methotrexate for rheumatoid arthritis. J Control Release. 2017;252:62–72. doi:10.1016/j.jconrel.2017.03.01228288894
   PubMed Web of Science ®Google Scholar
• Lee J, Chung S, Cho H, Kim D. Iodinated hyaluronic acid oligomer-based nanoassemblies for tumor-targeted drug delivery and cancer imaging. Biomaterials. 2016;85:218–231. doi:10.1016/j.biomaterials.2016.01.06026874284
   PubMed Web of Science ®Google Scholar
• Li Q, Chen Y, Zhou X, et al. Hyaluronic acid-methotrexate conjugates coated magnetic polydopamine nanoparticles for multimodal imaging-guided multistage targeted chemo-photothermal therapy. Mol Pharm. 2018;15:4049–4062. doi:10.1021/acs.molpharmaceut.8b0047330011996
   PubMed Web of Science ®Google Scholar
• Sargazi A, Kamali N, Shiri F, Heidari Majd M. Hyaluronic acid/polyethylene glycol nanoparticles for controlled delivery of mitoxantrone. Artif Cells Nanomed Biotechnol. 2018;46:500–509. doi:10.1080/21691401.2017.132446228503952
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang F, Li M, et al. Self-stabilized hyaluronate nanogel for intracellular codelivery of doxorubicin and cisplatin to osteosarcoma. Advan Sci. 2018;5:1700821. doi:10.1002/advs.201700821
   Web of Science ®Google Scholar
• Shirbin S, Ladewig K, Fu Q, et al. Cisplatin-induced formation of biocompatible and biodegradable polypeptide-based vesicles for targeted anticancer drug delivery. Biomacromolecules. 2015;16:2463–2474. doi:10.1021/acs.biomac.5b0069226166192
   PubMed Web of Science ®Google Scholar
• Huynh V, Chen G, de Souza P, Stenzel M. Thiol-yne and thiol-ene “click” chemistry as a tool for a variety of platinum drug delivery carriers, from statistical copolymers to crosslinked micelles. Biomacromolecules. 2011;12:1738–1751. doi:10.1021/bm200135e21476525
   PubMed Web of Science ®Google Scholar
• Xu C, Wang Y, Guo Z, et al. Pulmonary delivery by exploiting doxorubicin and cisplatin co-loaded nanoparticles for metastatic lung cancer therapy. J Control Release. 2019;295:153–163. doi:10.1016/j.jconrel.2018.12.01330586598
   PubMed Web of Science ®Google Scholar
• Wang Z, Yu Y, Dai W, et al. The use of a tumor metastasis targeting peptide to deliver doxorubicin-containing liposomes to highly metastatic cancer. Biomaterials. 2012;33:8451–8460. doi:10.1016/j.biomaterials.2012.08.03122940213
   PubMed Web of Science ®Google Scholar
• Xiao K, Li Y, Luo J, et al. The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles. Biomaterials. 2011;32:3435–3446. doi:10.1016/j.biomaterials.2011.01.02121295849
   PubMed Web of Science ®Google Scholar
• Sun D, Ding J, Xiao C, Chen J, Zhuang X, Chen X. Preclinical evaluation of antitumor activity of acid-sensitive PEGylated doxorubicin. ACS Appl Mater Interfaces. 2014;6:21202–21214. doi:10.1021/am506178c25415351
   PubMed Web of Science ®Google Scholar
• Lou C, Tian X, Deng H, Wang Y, Jiang X. Dialdehyde-beta-cyclodextrin-crosslinked carboxymethyl chitosan hydrogel for drug release. Carbohydr Polym. 2020;231:115678. doi:10.1016/j.carbpol.2019.11567831888806
   PubMed Web of Science ®Google Scholar
• Xiong S, Wang Z, Liu J, et al. A pH-sensitive prodrug strategy to co-deliver DOX and TOS in TPGS nanomicelles for tumor therapy. Colloids Surf B Biointerfaces. 2019;173:346–355. doi:10.1016/j.colsurfb.2018.10.01230316081
   PubMed Web of Science ®Google Scholar
• Du J-Z, Du X-J, Mao C-Q, Wang J. Tailor-made dual pH-sensitive polymer–doxorubicin nanoparticles for efficient anticancer drug delivery. J Am Chem Soc. 2011;133:17560–17563. doi:10.1021/ja207150n21985458
   PubMed Web of Science ®Google Scholar
• Pei M, Pai JY, Du P, Liu P. Facile synthesis of fluorescent hyper-cross-linked beta-cyclodextrin-carbon quantum dot hybrid nanosponges for tumor theranostic application with enhanced antitumor efficacy. Mol Pharm. 2018;15:4084–4091. doi:10.1021/acs.molpharmaceut.8b0050830040427
   PubMedGoogle Scholar
• Liu W, Liu H, Peng X, et al. Hypoxia-activated anticancer prodrug for bioimaging, tracking drug release, and anticancer application. Bioconjug Chem. 2018;29:3332–3343. doi:10.1021/acs.bioconjchem.8b0051130192132
   PubMed Web of Science ®Google Scholar